Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous adipose-derived mesenchymal stem cell injection for chronic discogenic low back pain
IRCT20131124015515N4Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2019
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of autologous adipose-derived mesenchymal stromal cells in discogenic back pain and degenerative disc disease (DDD), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Pain level and Disability. Started Jan 2019; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
discogenic back paindegenerative disc disease (DDD)
Beyond the preview
Go deeper on IRCT20131124015515N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20131124015515N4.